A Phase Ib, Open‐Label Study of Dalantercept, an Activin...

The Oncologist 2019 / 02 Vol. 24; Iss. 2

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

Abou‐Alfa, Ghassan K., Miksad, Rebecca A., Tejani, Mohamedtaki A., Williamson, Stephen, Gutierrez, Martin E., Olowokure, Olugbenga O., Sharma, Manish R., El Dika, Imane, Sherman, Matthew L., Pandya, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0654
Date:
February, 2019
File:
PDF, 364 KB
english, 2019
Conversion to is in progress
Conversion to is failed